Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: A randomised phase 2 study

Ahmad Awada, Agustin A. Garcia, Stephen Chan, Guy H.M. Jerusalem, Robert E. Coleman, Manon T. Huizing, Aminder Mehdi, Sue M. O'Reilly, John T. Hamm, Peter J. Barrett-Lee, Veronique Cocquyt, Kostandinos Sideras, David E. Young, Carol Zhao, Yen Lin Chia, Ute Hoch, Alison L. Hannah, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: A randomised phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences